Key result
Infusion of the ETA receptor antagonist BQ-123 induced significant vasodilation in the common femoral artery of older adults (5.1%) but not young adults (-0.8%), without augmenting mean shear rate.
Why the study?
Does BQ-123 infusion alter common femoral artery shear rate in young and old individuals?
Does BQ-123 infusion alter common femoral artery shear rate in young and old individuals?
Answers are grounded in this paper and cite their sources.
Endothelin-1 exerts powerful age-specific vasoconstriction in the common femoral artery, but its inhibition does not augment mean shear rate in older individuals.
BACKGROUND: Both altered shear rate and endothelin-1 (ET-1) are associated with the age-related development of atherosclerosis. However, the role of ET-1, a potent endogenous vasoconstrictor, in altering shear rate in humans, especially in the atherosclerotic-prone vasculature of the leg, is unknown. Therefore, this study examined the contribution of ET-1 to the age-related alterations in common femoral artery (CFA) shear rate. METHOD: BQ-123, a specific endothelin type A (ET(A)) receptor antagonist, was infused into the CFA, and diameter and blood velocity were measured by Doppler ultrasound in young (n = 8, 24 ± 2 years) and old (n = 9, 70 ± 2 years) study participants. RESULTS AND CONCLUSION: The old had greater intima-media thickening in the CFA, indicative of a preatherogenic phenotype. Prior to infusion, the old study participants exhibited reduced mean shear rate (27 ± 3/s) compared with the young study participants (62 ± 9/s). This difference was likely driven by attenuated antegrade shear rate in the old as retrograde shear rate was similar in the young and old. Inhibition of ETA receptors, by BQ-123, increased leg blood flow in the old, but not in the young, abolishing age-related differences. Older study participants had a larger CFA (young: 0.82 ± 0.03 cm, old: 0.99 ± 0.03 cm) in which BQ-123 induced significant vasodilation (5.1 ± 1.0%), but had no such effect in the young (-0.8 ± 0.8%). Interestingly, despite the age-specific, BQ-123-induced increase in leg blood flow and CFA diameter, shear rate patterns remained largely unchanged. Therefore, ET-1, acting through the ETA receptors, exerts a powerful age-specific vasoconstriction. However, removal of this vasoconstrictor stimulus does not augment mean shear rate in the old.
No takes yet. Share an insight, caveat, or question.
Trinity et al. (2015) studied Age-related alterations in common femoral artery shear rate (n=17). BQ-123 vs. Young participants was evaluated on Common femoral artery vasodilation. Infusion of the ETA receptor antagonist BQ-123 induced significant vasodilation in the common femoral artery of older adults (5.1%) but not young adults (-0.8%), without augmenting mean shear rate.
Synapse has enriched 10 related papers. Consider them for comparative context: